Cancers with Higher Density of Tumor-Associated Macrophages Were Associated with Poor Survival Rates
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: Macrophages are a component of a tumor’s microenvironment and have various roles in tumor progression and metastasis. This study evaluated the relationships between tumorassociated macrophage (TAM) density and clinical outcomes in 14 different types of human cancers. Methods: We investigated TAM density in human tissue microarray sections from 14 different types of human cancers (n = 266) and normal thyroid, lung, and breast tissues (n = 22). The five-year survival rates of each cancer were obtained from the 2011 Korea Central Cancer Registry. Results: Among 13 human cancers, excluding thyroid cancer, pancreas, lung, and gallbladder cancers had the highest density of CD163-positive macrophages (7.0 ± 3.5%, 6.9 ± 7.4%, and 6.9 ± 5.5%, respectively). The five-year relative survival rates of these cancers (pancreas, 8.7%; lung, 20.7%; gallbladder, 27.5%) were lower than those of other cancers. The histological subtypes in thyroid cancer exhibited significantly different CD163-positive macrophages densities (papillary, 1.8 ± 1.6% vs anaplastic, 22.9 ± 17.1%; p < .001), but no significant difference between histological subtypes was detected in lung and breast cancers. Moreover, there was no significant difference in CD163-positive macrophages densities among the TNM stages in lung, breast, and thyroid cancers. Conclusions: Cancers with higher TAM densities (pancreas, lung, anaplastic thyroid, and gallbladder) were associated with poor survival rate.
Abstract
Background: Macrophages are a component of a tumor’s microenvironment and have various roles in tumor progression and metastasis. This study evaluated the relationships between tumorassociated macrophage (TAM) density and clinical outcomes in 14 different types of human cancers. Methods: We investigated TAM density in human tissue microarray sections from 14 different types of human cancers (n = 266) and normal thyroid, lung, and breast tissues (n = 22). The five-year survival rates of each cancer were obtained from the 2011 Korea Central Cancer Registry. Results: Among 13 human cancers, excluding thyroid cancer, pancreas, lung, and gallbladder cancers had the highest density of CD163-positive macrophages (7.0 ± 3.5%, 6.9 ± 7.4%, and 6.9 ± 5.5%, respectively). The five-year relative survival rates of these cancers (pancreas, 8.7%; lung, 20.7%; gallbladder, 27.5%) were lower than those of other cancers. The histological subtypes in thyroid cancer exhibited significantly different CD163-positive macrophages densities (papillary, 1.8 ± 1.6% vs anaplastic, 22.9 ± 17.1%; p < .001), but no significant difference between histological subtypes was detected in lung and breast cancers. Moreover, there was no significant difference in CD163-positive macrophages densities among the TNM stages in lung, breast, and thyroid cancers. Conclusions: Cancers with higher TAM densities (pancreas, lung, anaplastic thyroid, and gallbladder) were associated with poor survival rate.
참고문헌 (30)
- Coussens LM, "Inflammation and cancer", Nature, 420, pp.860~867 (2002)
- 조선욱, "면역세포와 암세포의 상호작용", International Journal of Thyroidology, 6(2), pp.96~100 (2013), 대한갑상선학회
- Zhang QW, "Prognostic significance of tumorassociated macrophages in solid tumor: a meta-analysis of the literature", PLoS One, 7, pp.e50946~ (2012)
- Bingle L, "The role of tumour-associated macrophages in tumour progression : implications for new anticancer therapies", J Pathol, 196, pp.254~265 (2002)
- 김승환, "The Expression of Tumor-Associated Macrophages in Papillary Thyroid Carcinoma", Endocrinology and Metabolism, 28(3), pp.192~198 (2013), 대한내분비학회
- Zeni E, "Macrophage expression of interleukin-10 is a prognostic factor in nonsmall cell lung cancer", Eur Respir J, 30, pp.627~632 (2007)
- Campbell MJ, "Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome", Breast Cancer Res Treat, 128, pp.703~711 (2011)
- Sato S, "Macrophage stimulating protein promotes liver metastases of small cell lung cancer cells by affecting the organ microenvironment", Clin Exp Metastasis, 30, pp.333~344 (2013)
- Forssell J, "High macrophage infiltration along the tumor front correlates with improved survival in colon cancer", Clin Cancer Res, 13, pp.1472~1479 (2007)
- Ohno S, "The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients", Anticancer Res, 23, pp.5015~5022 (2003)
- Welsh TJ, "Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer", J Clin Oncol, 23, pp.8959~8967 (2005)
- Kawai O, "Predominant infiltration of macrophages and CD8(+) T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer", Cancer, 113, pp.1387~1395 (2008)
- Ohno S, "Correlation of histological localization of tumor-associated macrophages with clinicopathological features in endometrial cancer", Anticancer Res, 24, pp.3335~3342 (2004)
- Cho SW, "Therapeutic potential of Dickkopf-1in wild-type BRAF papillary thyroid cancer via regulation of betacatenin", E-cadherin signaling, 2014, pp.99, E1641~E1649
- 정규원, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2011", Cancer Research and Treatment, 46(2), pp.109~123 (2014), 대한암학회
- Cornett WR, "Anaplastic thyroid carcinoma:an overview", Curr Oncol Rep, 9, pp.152~158 (2007)
- Are C, "Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches", Ann Surg Oncol, 13, pp.453~464 (2006)
- Smallridge RC, "Anaplastic thyroid carcinoma: pathogenesis and emerging therapies", Clin Oncol (R Coll Radiol), 22, pp.486~497 (2010)
- Haymart MR, "Marginal treatment benefit in anaplastic thyroid cancer", Cancer, 119, pp.3133~3139 (2013)
- Lin JD, "A 29-year retrospective review of papillary thyroid cancer in one institution", Thyroid, 17, pp.535~541 (2007)
- Murri AM, "The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer", Br J Cancer, 99, pp.1013~1019 (2008)
- Medrek C, "The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients", BMC Cancer, 12, pp.306~ (2012)
- Ohtaki Y, "Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma", J Thorac Oncol, 5, pp.1507~1515 (2010)
- Zhang BC, "Tumor-associated macrophages infiltration is associated with peritumoral lymphangiogenesis and poor prognosis in lung adenocarcinoma", Med Oncol, 28, pp.1447~1452 (2011)
- Ma J, "The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time", BMC Cancer, 10, pp.112~ (2010)
- Al-Shibli K, "The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma", Histopathology, 55, pp.301~312 (2009)
- Steele RJ, "Oestrogen receptor concentration and macrophage infiltration in human breast cancer", Eur J Surg Oncol, 12, pp.273~276 (1986)
- Pollard JW, "Tumour-educated macrophages promote tumour progression and metastasis", Nat Rev Cancer, 4, pp.71~78 (2004)
- Heusinkveld M, "Identification and manipulation of tumor associated macrophages in human cancers", J Transl Med, 9, pp.216~ (2011)
- Ambarus CA, "Systematic validation of specific phenotypic markers for in vitro polarized human macrophages", J Immunol Methods, 375, pp.196~206 (2012)